Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)
0.3270
+0.0070 (2.19%)
Last updated: Oct 22, 2026, 5:29 PM CEST
EPA:ALOPM Market Cap
EPA:ALOPM has a market cap or net worth of €6.23 million as of October 22, 2026. It is the 43,361st most valuable company in the world and the 579th biggest in France. Its market cap has decreased by 18.20% in one year.
Market Cap
6.23M
Enterprise Value
10.49M
Revenue
1.82M
Global Rank
Country Rank
#579 France
PE Ratio
n/a
ChartMarket Cap Chart
Since October 5, 2022, EPA:ALOPM's market cap has increased from 5.82M to 6.23M, an increase of 6.91%. That is a compound annual growth rate of 1.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 6.23M | -16.61% |
| Dec 31, 2025 | 7.47M | -42.44% |
| Dec 31, 2024 | 12.97M | -56.74% |
| Dec 29, 2023 | 29.99M | 155.14% |
| Dec 30, 2022 | 11.75M | 101.80% |
| Oct 5, 2022 | 5.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| genOway Société anonyme | 20.28M |
| GenSight Biologics | 17.47M |
| Biophytis | 11.27M |
| Aton | 10.27M |
| TME Pharma | 10.22M |
| Poxel | 10.21M |
| Aelis Farma | 9.68M |
| Advicenne | 9.53M |